FDA rejects Intarcia's drug pump By: Boston Business Journal via Business Journals September 28, 2017 at 06:59 AM EDT The FDA sent bad news to Intarcia Therapeutics, rejecting aspects of its manufacturing plan for a matchstick-sized drug pump for the treatment of Type 2 diabetes. Read More >> Related Stocks: Commercial Metals Company
